Virus infection, inflammation and prevention of cancer.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-642-38965-8_3PMID 24008292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

  2012cited by this paper
• Tim‐3 regulates pro‐ and anti‐inflammatory cytokine expression in human CD14+ monocytes

  2012cited by this paper
• New developments in HCV therapy

  2012cited by this paper
• Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage‐mediated chronic inflammation

  2012cited by this paper
• Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.

  2012cited by this paper
• Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?

  2011cited by this paper
• Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.

  2011cited by this paper
• Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice.

  2011cited by this paper
• Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

  2011cited by this paper
• Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation

  2011cited by this paper
• Senescence surveillance of pre-malignant hepatocytes limits liver cancer development

  2011cited by this paper
• Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

  2011cited by this paper
• Coxibs and Other Nonsteroidal Anti-Inflammatory Drugs in Animal Models of Cancer Chemoprevention

  2011cited by this paper
• Mechanisms of hepatic fibrogenesis.

  2011cited by this paper
• Therapeutic targets in liver fibrosis.

  2011cited by this paper
• Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients.

  2011cited by this paper
• Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.

  2011cited by this paper
• B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis

  2011cited by this paper
• Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.

  2010cited by this paper
• Alternative activation of macrophages: mechanism and functions.

  2010cited by this paper
• Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice.

  2010cited by this paper
• Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3

  2010cited by this paper
• Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

  2010cited by this paper
• FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

  2010cited by this paper
• Prevention of Colitis-Associated Carcinogenesis with Infliximab

  2010cited by this paper
• Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

  2010cited by this paper
• Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

  2010cited by this paper
• Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.

  2010cited by this paper
• Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients

  2010cited by this paper
• Tim-3/Galectin-9 Pathway: Regulation of Th1 Immunity through Promotion of CD11b+Ly-6G+ Myeloid Cells

  2010cited by this paper
• CCL2 and Interleukin-6 Promote Survival of Human CD11b+ Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization*

  2009cited by this paper
• CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.

  2009cited by this paper
• Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis.

  2009cited by this paper
• The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors.

  2009cited by this paper
• Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe

  2009cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009cited by this paper
• The yin-yang of tumor-associated neutrophils.

  2009cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Microenvironmental regulation of metastasis

  2009cited by this paper
• Toll-like receptors and cancer

  2009cited by this paper
• Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability.

  2009cited by this paper
• Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.

  2009cited by this paper
• Infections and cancer: established associations and new hypotheses.

  2009cited by this paper
• Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

  2009cited by this paper
• Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

  2009cited by this paper
• Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

  2009cited by this paper
• Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection

  2009cited by this paper
• Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion

  2009cited by this paper
• Tumour necrosis factor and cancer

  2009cited by this paper
• CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages.

  2009cited by this paper
• IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

  2009cited by this paper
• Pan‐caspase inhibitor VX‐166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis

  2009cited by this paper
• Never underestimate the power of a neutrophil.

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

  2009cited by this paper
• Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies.

  2008cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4.

  2008cited by this paper
• Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.

  2008cited by this paper
• Positive and negative influences of regulatory T cells on tumour immunity

  2008cited by this paper
• A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer.

  2008cited by this paper
• Immunization With Analog Peptide in Combination With CpG and Montanide Expands Tumor Antigen-specific CD8+ T Cells in Melanoma Patients

  2008cited by this paper
• The role of myeloid cells in the promotion of tumour angiogenesis

  2008cited by this paper
• Current and future anti-fibrotic therapies for chronic liver disease.

  2008cited by this paper
• Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.

  2008cited by this paper
• The global impact of vaccination against hepatitis B: a historical overview.

  2008cited by this paper
• Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury.

  2008cited by this paper
• Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.

  2008cited by this paper
• The premetastatic niche

  2008cited by this paper
• NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α

  2008cited by this paper
• Mouse models for the study of HCV infection and virus–host interactions

  2008cited by this paper
• Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

  2008cited by this paper
• Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis

  2007cited by this paper
• A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C

  2007cited by this paper
• TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.

  2007cited by this paper
• Immune surveillance of tumors.

  2007cited by this paper
• Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

  2007cited by this paper
• Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.

  2007cited by this paper
• Adaptive immunity maintains occult cancer in an equilibrium state

  2007cited by this paper
• NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta.

  2007cited by this paper
• Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America.

  2007cited by this paper
• Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response1

  2007cited by this paper
• A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.

  2007cited by this paper
• Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

  2007cited by this paper
• Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update

  2007cited by this paper
• Inflammation and cancer: An ancient link with novel potentials

  2007cited by this paper
• TNF-α is critical for antitumor but not antiviral T cell immunity in mice

  2007cited by this paper
• Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.

  2007cited by this paper
• Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose.

  2007cited by this paper
• Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

  2007cited by this paper
• Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.

  2007cited by this paper
• Hepatocellular carcinoma pathogenesis: from genes to environment

  2006cited by this paper
• Human cancers express a mutator phenotype

  2006cited by this paper
• Restoring function in exhausted CD8 T cells during chronic viral infection

  2006cited by this paper
• The global health burden of infection‐associated cancers in the year 2002

  2006cited by this paper
• Hepatitis B virus infection: epidemiology and vaccination.

  2006cited by this paper
• Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

  2006cited by this paper
• Celecoxib for the prevention of colorectal adenomatous polyps.

  2006cited by this paper

• Prevention in Hepatology

  2024influential citation
• An inflammation-related gene landscape predicts prognosis and response to immunotherapy in virus-associated hepatocellular carcinoma

  2023cites this paper
• Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?

  2023cites this paper
• Role of Histone Post-Translational Modifications in Inflammatory Diseases

  2022cites this paper
• Theories and definitions of tumors

  2020cites this paper
• Hydroxysafflor yellow A inhibited lipopolysaccharide‐induced non‐small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways

  2019cites this paper
• Pathogenic Role of Exosomes in Epstein-Barr Virus (EBV)-Associated Cancers

  2017cites this paper
• COX-2 induces lytic reactivation of EBV through PGE2 by modulating the EP receptor signaling pathway.

  2015cites this paper
• The cancer burden attributable to biologic agents.

  2015cites this paper
• Cytomegalovirus and glioma: putting the cart before the horse

  2014cites this paper
• Cytokinome profile evaluation in patients with hepatitis C virus infection.

  2014cites this paper
• Medicinal properties of Hericium erinaceus and its potential to formulate novel mushroom-based pharmaceuticals

  2014cites this paper